$16.17
-1.01-5.88%
At Close: -
$16.17
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Entrada Therapeutics
TRDANASDAQ
Entrada Therapeutics (NASDAQ:TRDA) Stock, Earnings Estimates, EPS, And Revenue
Entrada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 6
EPS Estimate
$0.140
Quarterly Revenue Estimate
$46.1M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$162.9M
Analyze the earnings history of Entrada Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics | -$0.78 | $0.14 | — | — | $18.17M | $46.07M | — | — | 08/06/2024 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.21 | -$0.59 | $0.68 | 215.25% | $25.26M | $14.98M | $59.12M | 294.66% | 05/07/2024 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.79 | -$0.17 | -$0.29 | -70.59% | $0.00 | $23.69M | $41.85M | 76.65% | 03/13/2024 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.80 | -$0.74 | $1.02 | 237.84% | $0.00 | $9.60M | $43.73M | 355.57% | 11/07/2023 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.74 | — | -$0.78 | — | $0.00 | — | $18.17M | — | 08/08/2023 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.69 | — | -$0.21 | — | $0.00 | — | $25.26M | — | 05/10/2023 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.89 | -$0.83 | -$0.79 | 4.82% | $0.00 | — | $0.00 | — | 03/06/2023 | Get Alert |
| TRDA | Entrada Therapeutics | -$9.78 | -$0.76 | -$0.80 | -5.26% | $0.00 | — | $0.00 | — | 11/07/2022 | Get Alert |
| TRDA | Entrada Therapeutics | -$7.56 | — | -$0.74 | — | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| TRDA | Entrada Therapeutics | -$6.67 | — | -$0.69 | — | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| TRDA | Entrada Therapeutics | -$7.47 | — | -$0.89 | — | $0.00 | — | $0.00 | — | 03/15/2022 | Get Alert |
| TRDA | Entrada Therapeutics | -$6.13 | — | -$9.78 | — | $0.00 | — | $0.00 | — | 12/09/2021 | Get Alert |
Entrada Therapeutics (TRDA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-07 | $0.68 | $-0.59 | 215.3 % |
| Dec 2023 | 2024-03-13 | $-0.29 | $-0.17 | -70.6 % |
| Sep 2023 | 2023-11-07 | $1.02 | $-0.74 | 237.8 % |
| Dec 2022 | 2023-03-06 | $-0.79 | $-0.83 | 4.82 % |
Entrada Therapeutics (TRDA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-07 | $59.12M | $14.98M | 294.7 % |
| Dec 2023 | 2024-03-13 | $41.85M | $23.69M | 76.6 % |
| Sep 2023 | 2023-11-07 | $43.74M | $9.60M | 355.6 % |
FAQ
When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?
Entrada Therapeutics (TRDA) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
What were the latest earnings per share (EPS) for Entrada Therapeutics (NASDAQ:TRDA)?
The Actual EPS was $0.68, which beat the estimate of $-0.59.
What were Entrada Therapeutics’s (NASDAQ:TRDA) revenues?
The Actual Revenue was $59.1M, which beat the estimate of $15M.
Browse earnings estimates, EPS, and revenue on all stocks.